KR870700595A - 융합지환족 아미노알코올 - Google Patents

융합지환족 아미노알코올

Info

Publication number
KR870700595A
KR870700595A KR870700473A KR870700473A KR870700595A KR 870700595 A KR870700595 A KR 870700595A KR 870700473 A KR870700473 A KR 870700473A KR 870700473 A KR870700473 A KR 870700473A KR 870700595 A KR870700595 A KR 870700595A
Authority
KR
South Korea
Prior art keywords
amino alcohol
alicyclic amino
fused alicyclic
fused
alcohol
Prior art date
Application number
KR870700473A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858524491A external-priority patent/GB8524491D0/en
Priority claimed from GB868615560A external-priority patent/GB8615560D0/en
Application filed filed Critical
Publication of KR870700595A publication Critical patent/KR870700595A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/60—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
KR870700473A 1985-10-04 1987-06-03 융합지환족 아미노알코올 KR870700595A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB858524491A GB8524491D0 (en) 1985-10-04 1985-10-04 Fused cycloaliphatic aminoalcohols
GB868615560A GB8615560D0 (en) 1986-06-25 1986-06-25 Aminoalcohols
PCT/EP1986/000606 WO1987002035A1 (en) 1985-10-04 1986-09-29 Fused cycloaliphatic aminoalcohols

Publications (1)

Publication Number Publication Date
KR870700595A true KR870700595A (ko) 1987-12-30

Family

ID=26289843

Family Applications (1)

Application Number Title Priority Date Filing Date
KR870700473A KR870700595A (ko) 1985-10-04 1987-06-03 융합지환족 아미노알코올

Country Status (6)

Country Link
JP (1) JPH01503777A (ko)
KR (1) KR870700595A (ko)
AU (1) AU6548286A (ko)
DK (1) DK281187D0 (ko)
GR (1) GR862492B (ko)
WO (1) WO1987002035A1 (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1331191C (en) * 1988-03-25 1994-08-02 Bengt Ronny Andersson Therapeutically useful tetralin derivatives
IL109647A (en) * 1989-02-27 1997-04-15 Lilly Co Eli Intermediate compounds for ring-substituted 2-amino-1, 2, 3, 4-tetra- hydronaphthalenes and 3-aminochromanes
US5457121A (en) * 1994-09-02 1995-10-10 Eli Lilly And Company Cis-hexahydro-5-(1,2,3,4-tetrahydro-2-naphthalenyl)pyrrolo<3,4-c>pyrroles as inhibitors of serotonin reuptake
FR2769312B1 (fr) * 1997-10-03 1999-12-03 Adir Nouveaux composes de l'indanol, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DE10142666A1 (de) 2001-08-31 2003-03-20 Aventis Pharma Gmbh Verwendung von C2-substituierten Indan-1-ol-Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas
EP1833796A1 (en) * 2004-12-07 2007-09-19 Glaxo Group Limited Indenyl derivatives and use thereof for the treatment of neurological disorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2549685A (en) * 1948-09-30 1951-04-17 Upjohn Co Dioxy substituted 2-aminoindanols
FR1360532A (fr) * 1962-06-13 1964-05-08 Res Lab Dr C Janssen Nv Procédé de production de dérivés de la benzimidazolone et de leurs sels d'addition avec des acides
JPS561305B2 (ko) * 1972-12-18 1981-01-13
JPS50151853A (ko) * 1974-05-20 1975-12-06
US4018773A (en) * 1975-09-15 1977-04-19 E. R. Squibb & Sons, Inc. Phenylpiperazinotetrahydronaphthols and derivatives
DK309678A (da) * 1977-07-18 1979-01-19 Sandoz Ag Fremgangsmaade til fremstilling af tetralinderivater
US4189484A (en) * 1977-11-08 1980-02-19 Mitsubishi Yuka Pharmaceutical Co., Ltd. Antihypertensive quinazoline derivatives
US4533745A (en) * 1980-12-08 1985-08-06 Merck & Co., Inc. Amino ketones and their preparation

Also Published As

Publication number Publication date
GR862492B (en) 1987-02-03
WO1987002035A1 (en) 1987-04-09
DK281187A (da) 1987-06-02
DK281187D0 (da) 1987-06-02
JPH01503777A (ja) 1989-12-21
AU6548286A (en) 1987-04-24

Similar Documents

Publication Publication Date Title
DK30886A (da) Peptidderivater
KR870700360A (ko) 브레디키닌 길항근 펩티드
DK145386A (da) Ethanolaminer
DE3650689T2 (de) Rekombinantes inhibin
DK405386A (da) Antikonvulsante praeparater
DK600586A (da) Protein
IT1187425B (it) Astina per occhiali
DK133786D0 (da) Praeparater
DK419486D0 (da) Proteinekspression
DK414586A (da) Peptidforbindelser
KR870700595A (ko) 융합지환족 아미노알코올
DK461386D0 (da) Daegnlinser
ES542197A0 (es) Lentes bicurvoconicas
AT385445B (de) Zwinge
KR870003456U (ko) 거 울
ES541064A0 (es) Lentes conicas
ES542267A0 (es) Lentes bicurvas
DK384686A (da) Optikholder
DK411686D0 (da) Peptider
DK467785D0 (da) Peptider
DK528185D0 (da) Peptider
DK395685D0 (da) Peptider
SE8502358D0 (sv) Spegel
IT8586204A0 (it) Specchietto
ES286731Y (es) Porta-lente mejorado

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid